These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1376208)

  • 1. Relapsing disease.
    Murphy GP; Mahler C; Ho RC; Krane RJ; Pontes JE
    Cancer; 1992 Jul; 70(1 Suppl):368. PubMed ID: 1376208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostate-specific antigen as a prognostic parameter of treated prostate carcinoma--a reliable tumor marker?].
    Knönagel H; Gautschi K; Vonderschmitt DJ; Hauri D
    Helv Chir Acta; 1988 Jul; 55(3):333-5. PubMed ID: 2459081
    [No Abstract]   [Full Text] [Related]  

  • 3. Critical assessment of prostate cancer staging.
    Graham SD
    Cancer; 1992 Jul; 70(1 Suppl):269-74. PubMed ID: 1376195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer.
    Baker WC; Meyers FJ; White RW
    J Surg Oncol; 1988 Mar; 37(3):165-7. PubMed ID: 2451087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancer.
    Cooper EH; Armitage TG; Robinson MR; Newling DW; Richards BR; Smith PH; Denis L; Sylvester R
    Cancer; 1990 Sep; 66(5 Suppl):1025-8. PubMed ID: 1697498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and markers in prostate cancer.
    Flam TA; Brawer MK; Cooper EH; Javadpour N
    Cancer; 1992 Jul; 70(1 Suppl):357-8. PubMed ID: 1376206
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers in prostate cancer.
    Cooper EH; Robinson MR; Whelan P; Ferro MA
    Cancer; 1992 Jul; 70(1 Suppl):225-9. PubMed ID: 1376192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen in diagnosis, staging, and follow-up of prostate cancer.
    Cooper EH
    Prostate Suppl; 1992; 4():125-8. PubMed ID: 1374175
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum prostate-specific antigen: the most useful tumor marker.
    Andriole GL
    J Clin Oncol; 1992 Aug; 10(8):1205-7. PubMed ID: 1378885
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate specific antigen.
    Med Lett Drugs Ther; 1992 Oct; 34(880):93-4. PubMed ID: 1381807
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavior of prostatic specific antigen (PSA) in spinal fluid: its correlation with serum levels.
    Morote J; Ruibal A; Boada M
    Int J Biol Markers; 1986; 1(2):109-10. PubMed ID: 2448396
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
    Fosså SD; Waehre H; Paus E
    Br J Cancer; 1992 Jul; 66(1):181-4. PubMed ID: 1379059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?
    Sandler HM; DeSilvio ML
    J Natl Cancer Inst; 2003 Sep; 95(18):1352-3. PubMed ID: 13130102
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
    Taneja SS
    J Urol; 2015 Dec; 194(6):1631-2. PubMed ID: 26582665
    [No Abstract]   [Full Text] [Related]  

  • 15. Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?
    Schriefer P; Steurer S; Huland H; Graefen M
    J Clin Oncol; 2012 Nov; 30(32):e341-4. PubMed ID: 23032622
    [No Abstract]   [Full Text] [Related]  

  • 16. PSA as a treatment marker for prostate cancer?
    Miller M
    J Natl Cancer Inst; 1999 Jul; 91(13):1108-10. PubMed ID: 10393715
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting and monitoring results of therapy.
    Paulson DF
    J Urol; 1992 Mar; 147(3 Pt 2):967. PubMed ID: 1371569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of the immunohistochemical detection of PSA in the diagnosis of carcinoma of the prostate].
    Escaf S; Isorna S; Riesgo I
    Arch Esp Urol; 1987; 40(9):627-31. PubMed ID: 2449870
    [No Abstract]   [Full Text] [Related]  

  • 19. [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].
    Mazzola CR; Ghoneim T; Shariat SF
    Prog Urol; 2011 Jan; 21(1):1-10. PubMed ID: 21193139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of the search for specific prostatic antigens in fixed specimens].
    Stouffs M; Wilmus JP; Couvreur Y; Dossogne M
    Acta Urol Belg; 1984; 52(4):588-92. PubMed ID: 6083718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.